Category: Biotechnology Industry News

Biotechnology industry news, updates, and press releases

Kraig Biocraft Laboratories, Inc. Announces That It Has Successfully Created Transgenic Silkworm

Kraig Biocraft Laboratories, Inc. (OTC.BB:KBLB), a biotechnology company focused on the development of commercially significant high performance polymers including spider silk, today confirmed that scientists working in collaboration with the Company have successfully created transgenic silkworms. The silkworms were successfully genetically engineered with targeted spider silk DNA sequences. “We are very excited to be able […]


Bio Bank Helps Lethal Brain Cancer Patient Maintain Tissue Ownership Defy the Odds

HealthBank empowering patients with full ownership and control of their stored tumor tissue integral for tailored treatment courses; Six-year brain tumor survivor Bob Gibbs exemplifies the importance of banking tumor tissue for personalized cancer vaccines, which saved his own life Here’s something to wrap your brain around: tumors saves lives!  Few cancer patients realize that […]


Broad Institute acquires license to all ChemAxon products and deploys across Chemical Biology Platform.

Compound registration, structure search and computed properties rolled out. Budapest, Hungary and Cambridge, Massachusetts, 19 August 2010 – ChemAxon, a leading provider of chemistry software for life sciences, announced today that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon’s platform, discovery toolkits and desktop applications […]


BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine

Ness Ziona, Israel –  17 August 2010 – BiondVax Pharmaceuticals Ltd. (TASE: BNDX), an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a universal influenza vaccine, today announced that it has received the approvals of the Ethics (“Helsinki”) Committees of the Institutional Review Boards (IRB) of both the Hadassah Clinical […]


Headwaters MB Adds to Life Sciences Team

Headwaters MB announced that Don Warriner and Brad Rosborough have joined the firm as Managing Directors within the Life Sciences practice. Don Warriner joined Headwaters from Venture West Partners where he was focused on capital formation, sell-side and buy-side opportunities in software / technology companies.  Don previously was an executive at IBM and the CEO […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: